U. S. Steel Conference Call Available On Company Website
Get Alerts X Hot Sheet
Join SI Premium – FREE
PITTSBURGH, April 9, 2015 /PRNewswire/ -- United States Steel Corporation (NYSE: X) announced today that interested stockholders, investors and others may listen to the company's first quarter 2015 conference call with securities analysts on Wednesday, April 29, 2015, at 8:30 a.m. EDT. The call, which will be available via the U. S. Steel website, will cover first quarter 2015 financial results and may include forward-looking information. The company plans to release its first quarter 2015 financial results following the close of trading on the New York Stock Exchange on Tuesday, April 28.
U. S. Steel officials participating in the call will be Mario Longhi, president and CEO; David B. Burritt, executive vice president and CFO; and Dan Lesnak, general manager-investor relations.
To access the webcast and slides, visit the website at www.ussteel.com and click "Current Information" under the "Investors" section. Replays of the conference call will be available on the website after 10:30 a.m. on April 29.
Financial information, including earnings releases, certain SEC filings and other investor-related material, is also available at the company's website.
United States Steel Corporation, headquartered in Pittsburgh, Pa., is a leading integrated steel producer and Fortune 200 company with major production operations in the United States and Central Europe and an annual raw steelmaking capability of 24.4 million net tons. The company manufactures a wide range of value-added steel sheet and tubular products. For more information about U. S. Steel, please visit www.ussteel.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/u-s-steel-conference-call-available-on-company-website-300063270.html
SOURCE United States Steel Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EVI Industries acquires Sudsies, launches garment care division
- Ultragenyx Angelman syndrome drug fails Phase 3 trial endpoints
- Lianhe Sowell prices $11M follow-on stock offering on Nasdaq
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share